Oracle Investment Management as of March 31, 2020
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 15 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 60.2 | $192M | 2.0M | 97.81 | |
| Biohaven Pharmaceutical Holding | 21.0 | $67M | 2.0M | 34.03 | |
| Agenus (AGEN) | 4.1 | $13M | 5.4M | 2.45 | |
| Soleno Therapeutics | 2.9 | $9.2M | 3.9M | 2.38 | |
| Amarin Corporation (AMRN) | 2.7 | $8.7M | 2.2M | 4.00 | |
| Vermillion | 2.6 | $8.2M | 9.8M | 0.83 | |
| Opko Health (OPK) | 1.9 | $6.0M | 4.5M | 1.34 | |
| Pacific Biosciences of California (PACB) | 1.2 | $3.7M | 1.2M | 3.06 | |
| Antares Pharma | 0.9 | $2.9M | 1.2M | 2.36 | |
| Motus Gi Hldgs Incorporated | 0.8 | $2.6M | 3.8M | 0.67 | |
| Biolase | 0.6 | $1.9M | 5.2M | 0.38 | |
| Biogen Idec (BIIB) | 0.5 | $1.5M | 4.9k | 316.35 | |
| Contrafect Corp | 0.2 | $742k | 129k | 5.76 | |
| Y Mabs Therapeutics (YMAB) | 0.2 | $658k | 25k | 26.10 | |
| Accelr8 Technology | 0.2 | $636k | 4.5M | 0.14 |
